HDAC2 and breast carcinoma: HDACs, such as HDAC2, 4, and 5, have been shown to play a positive role in enhancing tumor progression and drug resistance in HR-positive breast cancer, which is related to their functions in regulating cell proliferation, differentiation, and autophagy [67,68,69,70].